GENERIC AVAILABLE: Yes
- Orphenadrine citrate tablets: 100 mg extended release
- Orphenadrine citrate solution for injection: 30 mg/ml
STORAGE: Tablets should be stored at room temperature, between 15 C and 30 C (59 F and 86 F).
DOSING: The recommended dose is one 100 mg tablet by mouth twice daily in the morning and evening.
Orphenadrine may cause drowsiness. Taking orphenadrine with other drugs that have similar CNS depressant effects may increase the CNS depressant effects of orphenadrine.
Orphenadrine may cause anticholingeric side effects such as:
Taking medications that also have anticholingeric effects increases the anticholinergic effect of orphenadrine.
PREGNANCY: Orphenadrine has not been adequately evaluated in pregnant females and is classified as pregnancy risk category C (adverse effects in animals but inadequate data in humans). Due to the lack of conclusive safety data, orphenadrine should be avoided in pregnancy if possible.
NURSING MOTHERS: It is not known whether orphenadrine is secreted into breast milk. Orphenadrine should be avoided in pregnancy if possible.
REFERENCE: FDA Prescribing Information.
Quick GuideChronic Pain: Causes, Solutions and Management
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Need help identifying pills and medications?
Use the pill identifier tool on RxList.